Evidence map›Paper›PMID 24822172›Full record

ReviewFrontiers in cellular and infection microbiology2014

The cyclic-di-GMP signaling pathway in the Lyme disease spirochete, Borrelia burgdorferi.

Elizabeth A Novak, Syed Z Sultan, Md A Motaleb

Abstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. TheInfection and immunity · 2026
    Article
  2. Virulence Regulation inMicroorganisms · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. bioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Gene Regulation and Transcriptomics.Current issues in molecular biology · 2021
    Article
  13. Interactions Between Ticks and Lyme Disease Spirochetes.Current issues in molecular biology · 2021
    Article
  14. TheFrontiers in microbiology · 2021
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Elizabeth A NovakDepartment of Microbiology and Immunology, East Carolina University Brody School of Medicine Greenville, NC, USA.
Syed Z SultanDepartment of Microbiology and Immunology, East Carolina University Brody School of Medicine Greenville, NC, USA.
Md A MotalebDepartment of Microbiology and Immunology, East Carolina University Brody School of Medicine Greenville, NC, USA.

Funding

Delineation of Borrelia burgdorferi motility and chemotaxis in the development ofR01AR060834 · NIAMS · EAST CAROLINA UNIVERSITY · PI MOTALEB, MD A · 2011 to 2015
$1.8M
NIAMS NIH HHS R01 AR060834NIAMS NIH HHS R01AR060834
6 · The paper itself

Abstract

In nature, the Lyme disease spirochete Borrelia burgdorferi cycles between the unrelated environments of the Ixodes tick vector and mammalian host. In order to survive transmission between hosts, B. burgdorferi must be able to not only detect changes in its environment, but also rapidly and appropriately respond to these changes. One manner in which this obligate parasite regulates and adapts to its changing environment is through cyclic-di-GMP (c-di-GMP) signaling. c-di-GMP has been shown to be instrumental in orchestrating the adaptation of B. burgdorferi to the tick environment. B. burgdorferi possesses only one set of c-di-GMP-metabolizing genes (one diguanylate cyclase and two distinct phosphodiesterases) and one c-di-GMP-binding PilZ-domain protein designated as PlzA. While studies in the realm of c-di-GMP signaling in B. burgdorferi have exploded in the last few years, there are still many more questions than answers. Elucidation of the importance of c-di-GMP signaling to B. burgdorferi may lead to the identification of mechanisms that are critical for the survival of B. burgdorferi in the tick phase of the enzootic cycle as well as potentially delineate a role (if any) c-di-GMP may play in the transmission and virulence of B. burgdorferi during the enzootic cycle, thereby enabling the development of effective drugs for the prevention and/or treatment of Lyme disease.

Indexed as

Signal Transduction3',5'-Cyclic-GMP PhosphodiesterasesAnimalsBacterial ProteinsBorrelia burgdorferiCarrier ProteinsCyclic GMPEscherichia coli ProteinsHumansLyme DiseasePhosphorus-Oxygen LyasesProtein Binding3',5'-Cyclic-GMP PhosphodiesterasesBacterial Proteinsbis(3',5')-cyclic diguanylic acidCarrier ProteinsCyclic GMPdiguanylate cyclaseEscherichia coli ProteinsPhosphorus-Oxygen LyasesBorrelia burgdorferic-di-GMPchemotaxisLyme diseasemotilityvirulence

Identifiers

PMID24822172
PMCPMC4013479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.